$PEPG
PepGen Inc.

2022 Q1 Form 10-Q Financial Statement

#000095017022011719 Filed on June 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.186M
YoY Change
% of Gross Profit
Research & Development $10.71M $5.530M
YoY Change 93.62%
% of Gross Profit
Depreciation & Amortization $100.0K $50.00K
YoY Change 100.0%
% of Gross Profit
Operating Expenses $13.89M $6.628M
YoY Change 109.61%
Operating Profit -$13.89M -$6.628M
YoY Change 109.61%
Interest Expense $9.000K
YoY Change
% of Operating Profit
Other Income/Expense, Net $67.00K -$8.000K
YoY Change -937.5%
Pretax Income -$13.83M -$6.636M
YoY Change 108.35%
Income Tax $4.400M
% Of Pretax Income
Net Earnings -$18.25M -$6.636M
YoY Change 174.95%
Net Earnings / Revenue
Basic Earnings Per Share -$18.94
Diluted Earnings Per Share -$814.8K
COMMON SHARES
Basic Shares Outstanding 963.6K
Diluted Shares Outstanding 963.6K

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $118.9M
YoY Change
Cash & Equivalents $118.9M $6.667M
Short-Term Investments
Other Short-Term Assets $2.240M
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables $4.574M
Total Short-Term Assets $125.7M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $2.569M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.642M
YoY Change
Total Long-Term Assets $6.211M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $125.7M
Total Long-Term Assets $6.211M
Total Assets $131.9M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.888M
YoY Change
Accrued Expenses $14.23M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $16.12M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $168.0K
YoY Change
Total Long-Term Liabilities $168.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $16.12M
Total Long-Term Liabilities $168.0K
Total Liabilities $16.29M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$52.00M
YoY Change
Common Stock $2.468M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$49.59M -$12.78M
YoY Change
Total Liabilities & Shareholders Equity $131.9M
YoY Change

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$18.25M -$6.636M
YoY Change 174.95%
Depreciation, Depletion And Amortization $100.0K $50.00K
YoY Change 100.0%
Cash From Operating Activities -$12.27M -$2.830M
YoY Change 333.64%
INVESTING ACTIVITIES
Capital Expenditures $1.614M $305.0K
YoY Change 429.18%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.614M -$305.0K
YoY Change 429.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -18.00K
YoY Change
NET CHANGE
Cash From Operating Activities -12.27M -2.830M
Cash From Investing Activities -1.614M -305.0K
Cash From Financing Activities -18.00K
Net Change In Cash -14.04M -3.111M
YoY Change 351.33%
FREE CASH FLOW
Cash From Operating Activities -$12.27M -$2.830M
Capital Expenditures $1.614M $305.0K
Free Cash Flow -$13.89M -$3.135M
YoY Change 342.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001835597
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-41374
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
PEPGEN INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3819886
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
245 Main Street
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02142
CY2022Q1 dei City Area Code
CityAreaCode
781
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
797-0979
CY2022Q1 dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
PEPG
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23631924
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118854000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
132895000
CY2022Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4574000
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4744000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2240000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2347000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
125668000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
139986000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2569000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
636000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3642000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3019000
CY2022Q1 us-gaap Assets
Assets
131879000
CY2021Q4 us-gaap Assets
Assets
143641000
CY2022Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
14000
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
33000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1888000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3240000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14234000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7081000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
16122000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10321000
CY2022Q1 pepg Preferred Stock Warrant Liability
PreferredStockWarrantLiability
168000
CY2021Q4 pepg Preferred Stock Warrant Liability
PreferredStockWarrantLiability
226000
CY2022Q1 us-gaap Liabilities
Liabilities
16290000
CY2021Q4 us-gaap Liabilities
Liabilities
10547000
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
165176000
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
165176000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2468000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1653000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-57000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
17000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51998000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33752000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-49587000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-32082000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
131879000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
143641000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10707000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5530000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3186000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1098000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
13893000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
6628000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13893000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6628000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
9000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
58000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
67000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13826000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6636000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4420000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-18246000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6636000
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-18.94
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.42
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
963588
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
894060
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-18246000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6636000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-74000
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
26000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18320000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6610000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-32082000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
815000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-18246000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-74000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-49587000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-6360000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
188000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6636000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
26000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-12782000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-18246000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6636000
CY2022Q1 us-gaap Depreciation
Depreciation
66000
CY2021Q1 us-gaap Depreciation
Depreciation
37000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
815000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
188000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-58000
CY2022Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-21000
CY2021Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-77000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-282000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
351000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1572000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
42000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-32000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
38000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6452000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3775000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12272000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2830000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1614000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
305000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1614000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-305000
CY2022Q1 pepg Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
18000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-137000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14041000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3111000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
134368000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9778000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
120327000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6667000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118854000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6667000
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
1473000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
120327000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6667000
CY2022Q1 pepg Property And Equipment Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
399000
CY2022Q1 pepg Deferred Offering Costs In Accounts Payable And Accrued Expenses
DeferredOfferingCostsInAccountsPayableAndAccruedExpenses
766000
CY2022Q1 pepg Proceeds From Issuance Initial Public Offering And Stock Options Exercised
ProceedsFromIssuanceInitialPublicOfferingAndStockOptionsExercised
122900000
CY2022Q1 pepg Net Proceeds From Issuance Initial Public Offering And Stock Options Exercised
NetProceedsFromIssuanceInitialPublicOfferingAndStockOptionsExercised
110200000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-52000000.0
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118900000
CY2022Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
2200000
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
0
CY2022Q1 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1500000
CY2020Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P10Y
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3040000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1066000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
471000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
430000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2569000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
636000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
50000.00
CY2022Q1 pepg Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
7718000
CY2021Q4 pepg Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
5343000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
635000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1205000
CY2022Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
4326000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1555000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
533000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14234000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7081000
CY2022Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.06
CY2022Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
0
CY2022Q1 us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
As of March 31, 2022 and December 31, 2021, all series of convertible preferred stock were convertible into shares of common stock on a one-to-one basis.
CY2022Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.018
CY2022Q1 us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
one vote for each share
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12582334
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 pepg Number Of Common Stock Vote
NumberOfCommonStockVote
1
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2022Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14959647
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
15006363
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1898084
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.46
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
176961
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.23
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2075045
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.78
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
230078
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.71
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2075045
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
7.78
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.50
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
815000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
188000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
9000000.0
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y4M24D
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4400000
CY2022Q1 pepg Expected Market Return
ExpectedMarketReturn
0.40
CY2022Q1 pepg Expected Market Return
ExpectedMarketReturn
0.40
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
700000
CY2020Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P10Y

Files In Submission

Name View Source Status
0000950170-22-011719-index-headers.html Edgar Link pending
0000950170-22-011719-index.html Edgar Link pending
0000950170-22-011719.txt Edgar Link pending
0000950170-22-011719-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pepg-20220331.htm Edgar Link pending
pepg-20220331.xsd Edgar Link pending
pepg-20220331_cal.xml Edgar Link unprocessable
pepg-20220331_def.xml Edgar Link unprocessable
pepg-20220331_htm.xml Edgar Link completed
pepg-20220331_lab.xml Edgar Link unprocessable
pepg-20220331_pre.xml Edgar Link unprocessable
pepg-ex31_1.htm Edgar Link pending
pepg-ex31_2.htm Edgar Link pending
pepg-ex32_1.htm Edgar Link pending
pepg-ex32_2.htm Edgar Link pending
pepg-ex3_1.htm Edgar Link pending
pepg-ex3_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending